ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation

DM Boeters; LE Burgers; EH Sasso; TWJ Huizinga; Annette van der Helm - van Mil

doi:10.1186/s13075-019-1902-2

ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation

DM Boeters, LE Burgers, EH Sasso, TWJ Huizinga, Annette van der Helm - van Mil

Rheumatology

Research output: Contribution to journal › Article › Academic › peer-review

19 Citations (Scopus)

7 Downloads (Pure)

Original language	Undefined/Unknown
Article number	121
Journal	Arthritis Research & Therapy
Volume	21
DOIs	https://doi.org/10.1186/s13075-019-1902-2
Publication status	Published - 2019

Access to Document

10.1186/s13075-019-1902-2

Repub_116840_O-A.pdfFinal published version, 629 KB

http://hdl.handle.net/1765/116840

Cite this

@article{9a8b417ae4a142c48b1ab57abc7b9bca,

title = "ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation",

author = "DM Boeters and LE Burgers and EH Sasso and TWJ Huizinga and {van der Helm - van Mil}, Annette",

year = "2019",

doi = "10.1186/s13075-019-1902-2",

language = "Undefined/Unknown",

volume = "21",

journal = "Arthritis Research & Therapy",

issn = "1478-6362",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation

AU - Boeters, DM

AU - Burgers, LE

AU - Sasso, EH

AU - Huizinga, TWJ

AU - van der Helm - van Mil, Annette

PY - 2019

Y1 - 2019

U2 - 10.1186/s13075-019-1902-2

DO - 10.1186/s13075-019-1902-2

M3 - Article

SN - 1478-6362

VL - 21

JO - Arthritis Research & Therapy

JF - Arthritis Research & Therapy

M1 - 121

ER -